Date | Dividend Yield | Free Cash Flow Yield | Earnings Yield | Enterprise Value (EV) |
---|
CEO | Dr. James R. Hollingshead Ph.D. |
IPO Date | May 15, 2007 |
Location | United States |
Headquarters | 100 Nagog Park |
Employees | 3,000 |
Sector | Health Care |
Industries |
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Past 5 years
USD 169.99
USD 62.54
USD 16.07
USD 79.17
USD 71.04
USD 362.80
USD 166.09
USD 113.02
USD 21.93
USD 79.30
USD 35.79
USD 252.89
USD 210.46
USD 147.95
StockViz Staff
January 15, 2025
Any question? Send us an email